Results 11 to 20 of about 9,610,135 (197)

Factors influencing the identification of it indirect costs: A case study [PDF]

open access: yes, 2008
Organizations expenditure on Information technology (IT) related investments continue to rise in the face of the fierce competition in the various marketplaces.
Ghoneim, A
core   +5 more sources

Cost of rheumatoid arthritis in a selected population from Argentina in the prebiologic therapy era

open access: yesClinicoEconomics and Outcomes Research, 2012
Erika Catay,1 Cecilia Castel del Cid,1 Lorena Narváez,1 Edson J Velozo,1 Javier E Rosa,1,2 Luis J Catoggio,1,2 Enrique R Soriano1,21Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, 2University Institute Hospital
Catay E   +6 more
doaj   +1 more source

Direct and indirect medical costs of bladder cancer in Iran

open access: yesCost Effectiveness and Resource Allocation, 2023
Abstract Background Bladder cancer is one of the most prevalent and costly cancers in the world. Estimating the economic burden of bladder cancer is essential for allocating resources to different sectors of health systems and determining the appropriate payment mechanisms.
Mehdi Raadabadi   +5 more
openaire   +3 more sources

Enhancing IT investments productivity: Integrating network QOS and it indirect costs [PDF]

open access: yes, 2006
Increasing productivity is considered one of the major driving factors for a successful business. From an Information Technology (IT) infrastructure perspective, obtaining an optimised performance of resources is expected to improve productivity.
El-Haddadeh, R, Ghoneim, A
core   +5 more sources

Indirect medical costs in early rheumatoid arthritis: Composition of and changes in indirect costs within the first three years of disease [PDF]

open access: yesArthritis & Rheumatism, 2001
To investigate 1) the magnitude of indirect costs, 2) changes in cost components, and 3) correlations between changes in cost and social, clinical, and occupational variables within the first 3 years of rheumatoid arthritis (RA).We evaluated the indirect costs per person-year in 133 consecutive gainfully employed out-patients with early RA, in a ...
S, Merkesdal   +5 more
openaire   +2 more sources

Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. [PDF]

open access: yes, 2012
BACKGROUND: The PACE trial compared the effectiveness of adding adaptive pacing therapy (APT), cognitive behaviour therapy (CBT), or graded exercise therapy (GET), to specialist medical care (SMC) for patients with chronic fatigue syndrome.
Anthony L. Johnson (124576)   +37 more
core   +1 more source

Cost Analysis of Haemodialysis Patients in Government Tertiary Care Centre – A Pharmacoeconomic Study

open access: yesPharmacology and Clinical Pharmacy Research, 2021
The progression of chronic kidney disease (CKD) to End-Stage Renal Disease (ESRD) in India is rapidly increasing. Over 25 million of people suffering from ESRD, especially in rural areas.
Manjula MJ   +3 more
doaj   +1 more source

The Cost of Maternal Complications and Its Associated Factors Among Mothers Attending Public Hospitals in Harari Region and Dire Dawa City Administration, Eastern Ethiopia: An Institution-Based Cross-Sectional Study

open access: yesClinicoEconomics and Outcomes Research, 2023
Samrawit Shawel,1 Behailu Hawulte Ayele,1 Yadeta Dessie,1 Abera Kenay Tura,2 Gimaye Dinsa,1,3 Abainash Tekola,1 Miheret Mandefro,1 Awoke Masrie,1 Aklilu Tamire,1 Obsan Kassa Tefasa1 1School of Public Health, Haramaya University, Harar, Ethiopia; 2School ...
Shawel S   +9 more
doaj  

Societal costs and health related quality of life in adult atopic dermatitis

open access: yesBMC Health Services Research, 2023
Background Cost-of-illness studies are widely used for healthcare decision-making in chronic conditions. Our aim was to assess the cost-of-illness of adult atopic dermatitis (AD) from the societal perspective in Hungary.
Zsuzsanna Beretzky   +9 more
doaj   +1 more source

The national economic burden of rare disease in the United States in 2019

open access: yesOrphanet Journal of Rare Diseases, 2022
Background To provide a comprehensive assessment of the total economic burden of rare diseases (RD) in the United States (U.S.) in 2019. We followed a prevalence-based approach that combined the prevalence of 379 RDs with the per-person direct medical ...
Grace Yang   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy